Highlighting education, research, and innovative medical technologies, the American Orthopaedic Society for Sports Medicine (AOSSM) conference was a great success. Both startup firms and companies with established market shares demonstrated new products, software, and technologies that gathered attention from physicians, clinicians, and allied healthcare professionals. With a full range of solutions that address the demanding needs of orthopedic and sports medicine care providers, the AOSSM conference was a great opportunity to learn about developments for the management of musculoskeletal treatment and rehabilitation protocols of sports injuries.
Discussions relating to arthroscopy, injury assessment and diagnosis, and soft tissue imaging, repair, as well as reconstruction device procedures were ongoing throughout the conference. Orthopedic sports medicine market leaders at the exhibition hall were excited to showcase their new and improved product offerings, with a heavy focus on repair and reconstruction of rotator cuff and ACL tears. Surgical video demonstrations, scientific paper presentations, hands-on training sessions, and question and answer sessions were provided to help orthopedic and sports medicine care providers refresh their knowledge and hone their skills in the recent, wide-ranging field of orthopedic sports medicine.
The morning general sessions on the first day focused on treatments of ACL revisions, repairs and reconstruction, recurrent patellar instability, as well as biologics, such as the use of micronized allograft articular cartilage and platelet-rich plasma to augment marrow stimulation and recombinant human parathyroid hormone on tendon-to-bone healing. The general sessions in the morning of the second day mainly discussed treatments of not only SLAP lesions and biceps tendonitis of the shoulder but also shoulder instability in athletes using open Bankart or Latarjet techniques, and open or arthroscopic procedure types. One of the studies that talked about clinical outcomes following recurrent anterior shoulder instability with combined bone loss using the arthroscopic revision stabilization and the modified Latarjet procedure, emphasized that recurrent instability is increasing. As a result, revision arthroscopy is growing in popularity as it provides surgeons with better visualization in a less invasive surgical manner.However, the study concluded that recurrent instability rates were higher in the arthroscopic patient group compared to the Latarjet group. Following this particular study result, there was debate concerning the indications of arthroscopic interventions for treatment of the shoulder. Since the treatment of the various shoulder instabilities has been the subject of controversial discussion over the last couple of decades and the recent study findings for arthroscopic anterior shoulder stabilization claimed that its procedure is increasingly used, surgeons and physicians at the conference tried to reach consensus that an individualized treatment plan based on the type and degree of instability and the patient's functional status was necessary. The afternoon sessions then covered the multiple studies about potential treatment options for meniscal and cartilage repair.
One of the interesting topics and product demonstrations that caught physicians? attention throughout the conference was regenerative medicine. Instead of reconstruction approaches, several studies covered topics ranging from in-vivo evaluations of a resorbable PLLA scaffold for regeneration of the ACL to mesenchymal stem cell injections. Those competitors in the niche segment of the sports medicine space featured their advanced regenerative medicine technologies, actively promoting their devices to physicians and advocating that regenerative medicine has benefits over traditional surgical methods for reconstruction of ligament and tendon tears. Additionally, sports medicine devices for pediatric patients attracted attention among both national and international orthopedic sports medicine leaders. Various surgical treatment options for ACL reconstruction and shoulder instabilities, as well as meniscus revision, along with preventative strategies for skeletally immature athletes were discussed in great detail.
While potential treatment options for musculoskeletal and medical health conditions continue to improve, physicians and sales representatives were putting effort into reaching an agreement on establishing best practices for device use. The exhibit hall was full of excitement in announcing that new product launches will occur throughout 2015, and the new offerings will be designed based on the functional demands of physicians and patients. With emphasis of the vital role of clinical insights in sports medicine and musculoskeletal injuries, physicians stated that they look forward to being able to implement an effective evaluation algorithm in this dynamic field as more treatment options become available.